×
返回 Agenda
Session Chair(s)
Jill Hartzler Warner
Associate Commissioner for Special Medical Programs, OC
FDA, United States
Speaker(s)
Latest US Regulatory and Policy Developments for Combination Products
Jill Hartzler Warner
FDA, United States
Associate Commissioner for Special Medical Programs, OC
Will the Regulatory Shifts in the US and the EU Make the US Market More Attractive to Innovators and the EU Less So? How Far Has the Balance Swung?
Rita M Peeters, PHARMD
Johnson & Johnson, Belgium
Executive Director, Regulatory Affairs EMEA MD&D
US and Global Moves towards the Regulation of Companion Diagnostics
Peter Martin
Roche Diagnostics, Germany
Senior Director Global Regulatory Affairs RPD